|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-4-25
|
|
pubmed:abstractText |
While current breast cancer chemoprevention strategies using selective estrogen response modulators and aromatase inhibitors are quite successful, their effects are limited to hormonally responsive breast cancer. Hormonally nonresponsive breast cancer (including estrogen receptor-negative cancer) is associated with poor prognosis for patients, and few chemoprevention agents exist for this type of cancer. The cyclooxygenase-2 inhibitor celecoxib (Celebrex) is a nonsteroidal anti-inflammatory drug and as such is a potential candidate for the prevention of hormonally nonresponsive breast cancer.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-10786667,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-11278747,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-11830510,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-12104042,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-12359744,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-12485462,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-12704673,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-1353410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-1400587,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-14693742,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-15161893,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-15179621,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-15687328,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-15964185,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-16018788,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-16707480,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-16818667,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-17285134,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-1861990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-1913683,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-2021942,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-6206131,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-9426408,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-9493977,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18279516-9747868
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1465-542X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
R18
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18279516-Animals,
pubmed-meshheading:18279516-Anticarcinogenic Agents,
pubmed-meshheading:18279516-Breast,
pubmed-meshheading:18279516-Breast Neoplasms,
pubmed-meshheading:18279516-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:18279516-Disease Models, Animal,
pubmed-meshheading:18279516-Female,
pubmed-meshheading:18279516-Pyrazoles,
pubmed-meshheading:18279516-Rats,
pubmed-meshheading:18279516-Rats, Inbred WF,
pubmed-meshheading:18279516-Sulfonamides,
pubmed-meshheading:18279516-Tamoxifen
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model.
|
|
pubmed:affiliation |
McArdle Laboratory for Cancer Research, University of Wisconsin, 1400 University Avenue, Madison, WI 53706, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|
